FDA to Ask Sarepta to Stop Shipping Muscular Dystrophy Drug Elevidys
Three patients with a deadly muscle-wasting disease died from liver failure after taking the therapy, Elevidys, or a similar treatment.
Source link
atOptions = {
'key' : '935d6ab39f70f5664bb173656c8b20f0',
'format' : 'iframe',
'height' : 250,
'width' : 300,
'params' : {}
};
